Skip to main content
JCO Precision Oncology logoLink to JCO Precision Oncology
. 2023 Feb 8;7:e2300024. doi: 10.1200/PO.23.00024

Erratum

PMCID: PMC10166471  PMID: 36753689

The article by Barroso-Sousa et al entitled “Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit” (JCO Precis Oncol 10.1200/PO.21.00413) was published online July 7, 2022, with an error.

In Figure 3, the same image was published in panels 3A and 3B. Figure 3 has been replaced.

This has been corrected as of February 8, 2023. JCO Precision Oncology apologizes for the error.


Articles from JCO Precision Oncology are provided here courtesy of American Society of Clinical Oncology

RESOURCES